The Virus Project will research the opportunities amidst this change with studies on emerging areas of investment in a post-covid economy. We will identify the market dynamics and the innovative companies and technologies. Reports in development include:
- Diagnostics and Anti-body Tests for COVID-19. Testing will be a vast multi billion industry as much of population will regularly test to determine their status. Hundreds of firms are working now to bring test to the market. We will soon publish research on 70 companies that have applied for approval at the US FDA. See Report Summary.
- Immune Health. Ultimately each person has great influence over whether they get COVID-19 and how they react once infected. Appreciation to immune health will emerge as people pay increased attention to what they eat and the chemicals that they ingest. We’ve begun a research to analysis 9 different key components to building immune health as well as tools to measure such.
Princeton based Sonnet Biotherapeutics [NASDAQ:SONN] has developed a unique, new and timely platform for the delivery of an enormous number of biologic drug applications for nearly any indication and has an interesting “Trojan Horse” approach that appears to have considerable promise with application in Covid – 19.